EMA — authorised 28 May 2015
- Marketing authorisation holder: Eisai Europe Ltd
- Status: approved
EMA authorised Lenvima on 28 May 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 28 May 2015.
Eisai Europe Ltd holds the EU marketing authorisation.